Corgenix Medical has received additional patent covering its AspirinWorks technology from the US Patent and Trademark Office. The patent is issued for the AspirinWorks Test Kit, which measures thromboxane metabolites in urine to evaluate ...
Tags: AspirinWorks technology, AspirinWorks test kit, Corgenix Medical
Athera Biotechnologies has released the results of a study which linked the low levels of plasma anti-PC, measured with Athera's CVDefine kit, to a high risk of vein graft failure after bypass surgery. The report is based on the data ...
Kaneka has unveiled KANEKA KanCapA, a new protein A chromatography resin to purify therapeutic antibodies. Protein A chromatography resin is widely used to produce antibodies due to its high affinity and excellent selectivity for ...
One Lambda (OLI ) has signed a supply agreement with CellTrend, which allows OLI to market and distribute the Immuno-Assay product, EIA. EIA is used for Quantitative Determination of anti-Angiotensin II Receptor 1 (AT1) Antibodies. The ...
pSivida has signed a funded technology evaluation agreement with a biopharmaceutical company to evaluate pSivida's Tethadur protein/antibody delivery technology in the field of ophthalmology. Tethadur, which uses an injectable, ...
CytoDyn has entered into an agreement to purchase Progenics Pharmaceuticals' proprietary humanized monoclonal antibody HIV viral-entry inhibitor drug candidate, PRO 140, for $3.5m. Upon successful continued clinical development of PRO ...
Tags: CytoDyn, HIV viral-entry inhibitor drug, humanized monoclonal antibody
CLC bio has implemented specialized antibody engineering and selection software for Crucell, one of the Janssen Pharmaceutical Companies of Johnson & Johnson, that integrates with CLC bio's bioinformatics platform. The specialized module ...
Tags: CLC bio, bioinformatics platform
Thermo Fisher Scientific has completed its acquisition of One Lambda, a transplant diagnostics company. One Lambda, which had 2011 revenue of $182m, will become part of Thermo Fisher's Specialty Diagnostics Segment. Thermo Fisher ...
Tags: Thermo Fisher Scientific, One Lambda's tests, transplant patients
The Health Canada has approved a label change for Biogen Idec's Tysabri to include anti-JC virus (JCV) antibody status as a risk factor for patients with multiple sclerosis (MS). The product monograph change will help enable ...
Tags: label change, Health Canada, risk assessment
ProImmune has introduced B cell ELISpot assay as a service for the characterization of adaptive immune responses to infection, immune modulators, vaccines and therapeutic agents. B cell ELISpot enables the activity of ...
RayBiotech-developed antibody-based biomarker screening assays have been used to identify a critical pathway involved in chemotherapeutic resistance acquired by melanoma cancer cells. RayBiotech president and chief operating officer ...
Tags: medical research, clinical technology, RayBiotech's antibody arrays
RayBiotech has signed a master services agreement with a West Coast-based biopharmaceutical company to provide custom services in the area of preclinical research diagnostic testing. RayBiotech will leverage its antibody array ...
Tags: company cooperation, clinical technology, clinical service
Biotechnology company Avaxia Biologics has received AVX-470 investigational new drug (IND) application clearance for the treatment of ulcerative colitis from the FDA. The bovine anti-tumor necrosis factor polyclonal antibody is based on ...
Tags: Avaxia, Ulcerative Colitis Therapy, IND
Cell Signaling Technology (CST) has developed monoclonal antibody discovery platform, NG-XMT, for antigen-specific monoclonal antibodies. The antibody discovery technology combines the power of proteomics to identify and clone ...
Tags: NG-XMT, clone, monoclonal antibodies
Sweden based Karolinska Institutet and Immunomedics scientists have collaborated to design and test new class of drugs that destroy the AIDS virus, HIV (Human Immunodeficiency Virus), which may also help in eliminating the virus completely. ...
Tags: Immunomedics, anti-HIV agents, virus